Skip to main content
Caplight Logo









Nurami Medical

Nurami Medical

Private
HaifaHealthcare & Life Scienceshttps://www.nurami-medical.com/

Last Round

Series C

Mar 4, 2025

Total Funding Raised

$46.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nurami Medical is a biotechnology company that develops and manufactures nanofiber-based products for soft tissue repair.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

surgical sealantdural patchcerebrospinal fluid leakageCSF leakageneurosurgical devicesbiodegradable implantssurgical graftelectrospun nanofibersdural repairbiomaterialssoft tissue repairmedtechsurgical consumablesimplantable devices

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nurami Medical Comparables

Compare Nurami Medical with similar companies based on industry and business-model similarity.

Nurami Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pramand
88%
Neomend
86%
Medprin Regenerative Medical Technologies Co. Ltd.
84%

Nurami Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 4, 2025
GrantJul 16, 2024
GrantJul 2, 2024
Series BNov 2, 2020
VC RoundJul 16, 2019
Series A
Jul 1, 2018

Key People

Founding team and executive leadership

Nora Nseir

Co-Founder and CEO

Founding Team

Mira Rosenzweig

Chief Financial Officer

Executive Team

Amir Bahar

Board Member, Chief Clinical Officer

Executive Team

Nurami Medical Investors

Notable investors and investment history

Nurami Medical investors
InvestorRounds
European Innovation Council FundGrant
huMannity MedtecVC Round, Seed
Israel Innovation AuthorityGrant, VC Round
Next Generation Technology (NGT3VC)Grant
GlenRock IsraelSeries B
Almeda VenturesSeries B
Iron NationSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 141% MoM, reaching 450.

  • Jul 16, 2024

    Secured $3M from European Innovation Council Fund and Israel Innovation Authority.

Nurami Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nurami Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nurami Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersHaifa
Employee Range34
Year Founded2014
Last FundingMar 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?